Merck and Bayer's heart drug meets main goal of late-stage study

Merck& Co Inc<MRK.N said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news